On Monday, psychedelic pharmaceutical research company PharmaDrug (CSE: BUZZ) (OTC Pink: LMLLF) appointed neuroscientist Dr. Steven A. Barker, Ph.D. to its newly-formed scientific advisory board. Dr. Barker will lead research and development regarding the mental health benefits of the powerful psychedelic compound Dimethyltryptamine, also known as DMT. Dr. Baker has been actively involved in the…